| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.15▲ | 5.11▲ | 5.05▲ | 5.32▼ | 5.43▼ |
| MA10 | 5.11▲ | 5.05▲ | 5.14▲ | 5.30▼ | 5.75▼ |
| MA20 | 5.04▲ | 5.21▼ | 5.30▼ | 5.44▼ | 5.91▼ |
| MA50 | 5.25▼ | 5.34▼ | 5.37▼ | 5.79▼ | 5.89▼ |
| MA100 | 5.31▼ | 5.42▼ | 5.64▼ | 5.95▼ | 7.00▼ |
| MA200 | 5.44▼ | 5.81▼ | 5.86▼ | 6.12▼ | 30.30▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.034▲ | 0.012▲ | -0.027▼ | 0.002▲ | -0.112▼ |
| RSI | 51.944▲ | 48.408▼ | 46.680▼ | 39.673▼ | 44.129▼ |
| STOCH | 100.000▲ | 55.389 | 43.424 | 39.151 | 18.326▼ |
| WILL %R | 0.000▲ | -31.667 | -59.000 | -68.103 | -90.237▼ |
| CCI | 76.709 | 42.254 | -32.814 | -147.641▼ | -123.372▼ |
|
Friday, August 07, 2026 12:04 PM
Verrica Pharmaceuticals (NASDAQ:VRCA) reported second-quarter revenue growth in its YCANTH treatment for molluscum contagiosum, while outlining progress in pivotal studies of the product for common ...
|
|
Thursday, August 06, 2026 01:01 PM
Facility will support YCANTH® commercialization, global Phase 3 program for YCANTH® in common warts and general corporate operations — — Facility provides potential for no scheduled interest or ...
|
|
Thursday, July 30, 2026 05:00 AM
WEST CHESTER, Pa., July 30, 2026 (GLOBE NEWSWIRE) -- (“Verrica” or “the Company”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/08/26 | 5.31 | 5.50 | 4.71 | 5.08 | 126,192 |
| 06/08/26 | 5.42 | 5.87 | 5.26 | 5.36 | 83,888 |
| 05/08/26 | 5.48 | 5.61 | 5.405 | 5.51 | 11,462 |
| 04/08/26 | 5.23 | 5.51 | 5.23 | 5.41 | 24,530 |
| 03/08/26 | 5.22 | 5.54 | 5.08 | 5.25 | 32,356 |
| 31/07/26 | 5.27 | 5.5543 | 5.22 | 5.22 | 4,793 |
| 30/07/26 | 5.235 | 5.3888 | 5.235 | 5.26 | 6,642 |
| 29/07/26 | 5.35 | 5.7895 | 5.00 | 5.18 | 30,909 |
| 28/07/26 | 5.66 | 5.86 | 5.3763 | 5.40 | 48,816 |
| 27/07/26 | 5.08 | 5.44 | 5.00 | 5.35 | 102,111 |
|
|
||||
|
|
||||
|
|